David Parrot Insider Profile
4 Followers
David Parrot, Chief Financial Officer at Scribe Therapeutics Inc., holds 2.67K shares in Scribe Therapeutics Inc. (Ticker: SCTX). Most recently, David Parrot Bought 2,666 shares of Scribe Therapeutics Inc. on Jul 27, 2026 for an estimated value of $39.99K.
David Parrot has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Chief Financial Officer
Roles that David Parrot holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by David Parrot
David Parrot's Trading History
List of latest transactions for each holding click on a transaction to see David Parrot's performance on stock
You May Also Like
David Parrot insider profile FAQ
What is the percentage of profitable transactions made by David Parrot?
The percentage of profitable transactions made by David Parrot is ―.
What is the average return per transaction made by David Parrot?
The average return per transaction made by David Parrot is ―.
What stocks does David Parrot hold?
David Parrot holds: SCTX stocks.
What was David Parrot’s latest transaction?
David Parrot latest transaction was an Informative Buy of $39.99K.
What was David Parrot's most profitable transaction?
David Parrot’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is David Parrot's role in Scribe Therapeutics Inc.?
David Parrot's role in Scribe Therapeutics Inc. is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.